Trials / Conditions / Vitreomacular Traction

Vitreomacular Traction

15 registered clinical trials studyying Vitreomacular Traction — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	UNITY VCS Vitreoretinal Surgery NCT07054281	Alcon Research	N/A
Completed	Zeiss RESIGHT Disposable Lenses Evaluation Study NCT05860985	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy NCT06038968	Minia University	EARLY_Phase 1
Completed	Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains NCT05517473	Universitaire Ziekenhuizen KU Leuven	—
Completed	Ocular Coherence Tomography During Cataract Assessment NCT05287269	Brighton and Sussex University Hospitals NHS Trust	—
Terminated	Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid NCT04300881	Wagner Macula & Retina Center	Phase 2
Completed	Effects of Pneumatic Vitreolysis on Vitreomacular Traction NCT03647267	Jaeb Center for Health Research	Phase 3
Unknown	Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery NCT05588037	Aier School of Ophthalmology, Central South University	N/A
Completed	Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion NCT02322229	Alcon Research	Phase 4
Recruiting	Vitreopapillary Interface and Optic Disc Morphology NCT02290795	Universitaire Ziekenhuizen KU Leuven	—
Completed	Assessment of Patients Treated With JETREA® for Vitreomacular Traction NCT02035748	Alcon Research	Phase 4
Completed	A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment NCT01966328	Jeffrey S Heier	Phase 1
Completed	Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study NCT01162356	Vanderbilt University	—
Unknown	Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel NCT00892619	Michael E. DeBakey VA Medical Center	N/A
Completed	A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Tract NCT00435539	ThromboGenics	Phase 2